Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis
Clinical trial NCT05105347 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05105347
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2026-12-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.